MetaVia Inc.
MetaVia Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 13 | 14 | 10 | 14 | 18 | 11 | 16 | 22 | 28 | 16 | 22 | 26 | |||||
Prepaid Expense Current | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | - | |||||
Assets Current | 13 | 14 | 11 | 15 | 18 | 12 | 16 | 22 | 29 | 17 | 23 | 26 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 13 | 14 | 11 | 15 | 18 | 12 | 16 | 22 | 29 | 17 | 23 | 26 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 1 | 1 | 1 | 3 | 3 | 3 | 4 | 1 | 3 | 2 | 1 | 2 | |||||
Shares Subject To Mandatory Redemption Settlement … | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | |||||
Other Liabilities Current | 2 | 3 | 3 | 3 | 4 | 2 | 1 | 3 | 4 | - | 1 | - | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | 6 | 5 | 6 | 8 | 9 | 8 | 8 | 9 | 10 | 7 | 6 | 5 | |||||
Operating Lease Liability Noncurrent | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Liabilities | 6 | 5 | 6 | 8 | 9 | 8 | 8 | 9 | 10 | 7 | 6 | 5 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 165 | 162 | 154 | 153 | 153 | 144 | 144 | 144 | 144 | 125 | 125 | 124 | |||||
Undesignated Preferred Stock | - | - | - | - | - | - | - | - | - | - | 0 | - | |||||
Retained Earnings Accumulated Deficit | -158 | -153 | -149 | -147 | -144 | -140 | -136 | -131 | -125 | -115 | -108 | -103 | |||||
Shared Services Agreement | - | - | - | - | - | - | - | - | - | - | 1 | - | |||||
Stockholders Equity | 7 | 9 | 5 | 6 | 10 | 4 | 8 | 13 | 19 | 10 | 17 | 22 | |||||
Accrued Liabilities Current | - | - | - | - | - | - | - | - | - | 4 | 4 | 2 | |||||
Liabilities And Stockholders Equity | 13 | 14 | 11 | 15 | 18 | 12 | 16 | 22 | 29 | 17 | 23 | 26 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |||||
Common Stock Shares Issued | 7 | 5 | 2 | 24 | 24 | 9 | 1 | 9 | 8 | 5 | 5 | 5 | |||||
Shares Outstanding | 7 | 5 | 2 | 24 | 24 | 9 | 1 | 9 | 8 | 5 | 5 | 5 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 115.97% | 24.37% | 19.33% | - | - | - | - | - | - | - | - | - |
| 2025 | 3.75% | -2.85% | -8.70% | -0.31% | 52.52% | 54.09% | -8.47% | -1.71% | -69.73% | 6.06% | -15.91% | 31.82% |
| 2024 | -4.63% | 21.15% | 3.88% | -10.26% | -30.00% | -31.54% | -4.85% | -34.33% | -28.36% | -6.45% | -52.97% | -55.35% |
| 2023 | - | - | - | -14.15% | -10.19% | -19.06% | 13.90% | 10.48% | 46.07% | -17.60% | 13.94% | -6.85% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 2.06 | 2.73 | 1.93 | 1.74 | 2.08 | 1.55 | 1.94 | 2.41 | 2.94 | 2.46 | 3.78 | 5.54 | |||||
| Quick Ratio | 1.99 | 2.64 | 1.82 | 1.69 | 1.99 | 1.45 | 1.94 | 2.38 | 2.88 | 2.34 | 3.76 | 5.47 | |||||
| Working Capital | 6.72M | 8.97M | 5.23M | 6.21M | 9.50M | 4.25M | 7.80M | 12.82M | 18.81M | 9.94M | 16.55M | 21.42M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.95 | 0.59 | 1.09 | 1.33 | 0.92 | 1.77 | 1.05 | 0.71 | 0.52 | 0.69 | 0.37 | 0.23 | |||||
| Interest Coverage TTM | -37.90 | -29.65 | -26.88 | -27.20 | -25.26 | -31.83 | -31.31 | -28.60 | -30.77 | -29.01 | -34.46 | -127.46 | |||||
| Debt Ratio | 0.49 | 0.37 | 0.52 | 0.57 | 0.48 | 0.64 | 0.51 | 0.42 | 0.34 | 0.41 | 0.27 | 0.18 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -2.44 | -2.70 | -7.35 | -0.66 | -13.31 | -26.31 | -39.13 | -2.72 | -4.77 | -3.26 | -2.46 | -2.33 | |||||
| Free Cash Flow Per Share TTM | -2.67 | -3.12 | -8.89 | -0.67 | -13.60 | -24.75 | -35.06 | -2.22 | -3.68 | -2.90 | -2.14 | -1.82 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Growth Metrics | |||||||||||||||||
| Net Income Growth (1Y) | -21.88% | -46.54% | -52.98% | -41.53% | -28.60% | 48.06% | 121.27% | 134.39% | 132.76% | 21.06% | -10.72% | -14.69% | |||||
| EPS Growth (1Y) | -81.70% | -89.73% | -81.23% | -75.54% | 178.90% | 707.58% | 1,491.15% | 16.48% | 116.90% | 20.33% | -94.34% | -98.13% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.59 | -0.44 | -1.15 | -15.57 | -0.53 | -0.64 | -0.57 | -12.84 | -11.16 | -13.81 | -16.54 | -17.97 | |||||
| P/B TTM | 1.24 | 0.64 | 2.79 | 39.88 | 1.02 | 3.61 | 1.99 | 27.50 | 15.26 | 22.72 | 12.36 | 9.87 | |||||
| Market Cap | 8.48M | 5.83M | 14.87M | 252.46M | 9.83M | 15.81M | 15.75M | 356.17M | 289.03M | 228.97M | 206.23M | 212.62M | |||||
| Enterprise Value | -4.15M | -7.90M | 4.59M | 238.18M | -7.76M | 4.62M | -270.04K | 334.50M | 261.10M | 212.98M | 183.79M | 186.78M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -15.84M | -15.15M | -15.70M | -16.31M | -18.91M | -23.09M | -24.72M | -22.66M | -19.96M | -14.75M | -10.85M | -9.25M | |||||
| Net Debt | -12.63M | -13.73M | -10.28M | -14.28M | -17.59M | -11.19M | -16.02M | -21.67M | -27.93M | -15.99M | -22.44M | -25.84M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
MetaVia Inc. (MTVA) — SEC Financial Statements & Analysis
MetaVia Inc. (MTVA) is a pharmaceutical preparations company, incorporated in DE. MetaVia Inc. trades on Nasdaq as: MTVA. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), MetaVia Inc. reported a Debt-to-Equity ratio of 0.95x, a Price-to-Book (P/B) ratio of 1.24x (TTM), at a market cap of $8.48M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- 0.95x
- P/B TTM
- 1.24x
- Market Cap
- $8.48M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is MetaVia Inc. in?
MetaVia Inc. (MTVA) operates in the Pharmaceutical Preparations industry.
What is MTVA's market cap?
MetaVia Inc. (MTVA) has a market capitalization of $8.48M as of 2026-06-30.
What exchange does MTVA trade on?
MetaVia Inc. (MTVA) trades on the Nasdaq.
Where is MetaVia Inc. incorporated?
MetaVia Inc. is incorporated in DE.